{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:04:12Z","timestamp":1789697052252,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":81,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cutaneous and mucosal melanoma are biologically and clinically distinct malignancies whose epidemiology varies markedly across populations and skin phototypes. In Arab and other Eastern Mediterranean populations, melanoma is comparatively uncommon but is frequently diagnosed at an advanced stage and shows a relatively high proportion of acral and mucosal subtypes. Data describing melanoma in the Palestinian population are scarce. We characterised the clinicopathological profile of cutaneous and mucosal melanoma diagnosed at a large Palestinian diagnostic pathology service and placed the findings in a comparative regional context.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective review of all histopathologically confirmed cases of cutaneous and mucosal melanoma reported at Medicare Diagnostic Laboratories, West Bank, Palestine, between May 2008 and May 2026. Demographic variables (age, sex), anatomical site, melanoma subtype, depth of invasion (Clark level), and, where recorded, Breslow thickness and American Joint Committee on Cancer (AJCC) stage were abstracted from pathology records. Diagnoses were confirmed on haematoxylin-eosin sections supported by immunohistochemistry (S100, SOX10, HMB-45, Melan-A). Repeat specimens were consolidated to the patient level, and findings were compared with published series from neighbouring countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifty-seven patients with primary melanoma were identified, comprising 47 cutaneous (82.5%) and 10 mucosal (17.5%) tumours. The mean age at diagnosis was 59.5 +\/- 17.0 years (range 10\u201387), and there was a slight female predominance (30 women, 52.6%; male-to-female ratio 0.90:1). Acral sites (sole, heel, plantar, and subungual regions) accounted for 15 of 47 cutaneous melanomas (31.9%), the most common single location, followed by the head and neck (14, 29.8%). Among mucosal tumours, the anorectum was the predominant site (6 of 10, 60%). A histological subtype was explicitly recorded in only 19 of 57 cases; within this limited subset the nodular pattern predominated (18 of 19), although the large proportion of cases without a stated subtype precludes firm conclusions about the true distribution of melanoma subtypes in this cohort. The Clark level was documented in 27 patients, of whom 26 (96.3%) had level IV-V (deep) invasion. A further 17 patients presented with metastatic melanoma deposits without a primary tumour in the archive.<\/jats:p>\n                    <jats:p>Melanoma in this Palestinian cohort was characterised by a slight female predominance, a high proportion of acral (31.9% of cutaneous) and mucosal (17.5% of all primary) tumours, a predominantly nodular phenotype among the subset of cases with a recorded subtype, and deep invasion at diagnosis. This profile mirrors patterns reported in neighbouring Arab and Eastern Mediterranean populations and contrasts with more lightly pigmented (Fitzpatrick I\u2013II) Western populations. The findings underline the need for improved melanoma awareness, routine examination of acral and mucosal sites, and strengthened cancer registration in Palestine.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-026-16393-5","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:43:04Z","timestamp":1782733384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cutaneous and mucosal melanoma among the Palestinian population: a retrospective clinicopathological study with comparative regional context"],"prefix":"10.1186","volume":"26","author":[{"given":"Ibrahim","family":"Salhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Bannoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orgina","family":"Abedaljawwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaidoun","family":"Salah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"3","key":"16393_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"16393_CR2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1001\/jamadermatol.2022.0160","volume":"158","author":"M Arnold","year":"2022","unstructured":"Arnold M, Singh D, Laversanne M, Vignat J, Vaccarella S, Meheus F, et al. Global burden of cutaneous melanoma in 2020 and projections to 2040. JAMA Dermatol. 2022;158(5):495\u2013503.","journal-title":"JAMA Dermatol"},{"issue":"10151","key":"16393_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","volume":"392","author":"D Schadendorf","year":"2018","unstructured":"Schadendorf D, van Akkooi ACJ, Berking C, Griewank KG, Gutzmer R, Hauschild A, et al. Melanoma Lancet. 2018;392(10151):971\u201384.","journal-title":"Melanoma Lancet"},{"issue":"6","key":"16393_CR4","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jid.2016.01.035","volume":"136","author":"DC Whiteman","year":"2016","unstructured":"Whiteman DC, Green AC, Olsen CM. The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031. J Invest Dermatol. 2016;136(6):1161\u201371.","journal-title":"J Invest Dermatol"},{"issue":"17","key":"16393_CR5","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1001\/archinte.166.17.1907","volume":"166","author":"JN Cormier","year":"2006","unstructured":"Cormier JN, Xing Y, Ding M, Lee JE, Mansfield PF, Gershenwald JE, et al. Ethnic differences among patients with cutaneous melanoma. Arch Intern Med. 2006;166(17):1907\u201314.","journal-title":"Arch Intern Med"},{"issue":"4","key":"16393_CR6","doi-asserted-by":"publisher","first-page":"500","DOI":"10.5858\/arpa.2019-0561-RA","volume":"144","author":"DE Elder","year":"2020","unstructured":"Elder DE, Bastian BC, Cree IA, Massi D, Scolyer RA. The 2018 World Health Organization classification of cutaneous, mucosal, and uveal melanoma: detailed analysis of 9 distinct subtypes defined by their evolutionary pathway. Arch Pathol Lab Med. 2020;144(4):500\u201322.","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"16393_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/archdermatol.2008.609","volume":"145","author":"PT Bradford","year":"2009","unstructured":"Bradford PT, Goldstein AM, McMaster ML, Tucker MA. Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986\u20132005. Arch Dermatol. 2009;145(4):427\u201334.","journal-title":"Arch Dermatol"},{"issue":"8","key":"16393_CR8","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","volume":"83","author":"AE Chang","year":"1998","unstructured":"Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer. 1998;83(8):1664\u201378.","journal-title":"Cancer"},{"issue":"8","key":"16393_CR9","first-page":"739","volume":"5","author":"M Mihajlovic","year":"2012","unstructured":"Mihajlovic M, Vlajkovic S, Jovanovic P, Stefanovic V. Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol. 2012;5(8):739\u201353.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"16393_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3390\/cancers16010227","volume":"16","author":"L Clavero-Rovira","year":"2024","unstructured":"Clavero-Rovira L, Gomez-Tomas A, Bassas-Freixas P, Bodet D, Ferrer B, Hernandez-Losa J, et al. Mucosal melanoma clinical management and prognostic implications: a retrospective cohort study. Cancers (Basel). 2024;16(1):227.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"16393_CR11","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3390\/cancers14030780","volume":"14","author":"A Carbo-Bague","year":"2022","unstructured":"Carbo-Bague A, Rubio-Casadevall J, Puigdemont M, Sanvisens A, Oliveras G, Coll M, et al. Epidemiology and molecular profile of mucosal melanoma: a population-based study in Southern Europe. Cancers (Basel). 2022;14(3):780.","journal-title":"Cancers (Basel)"},{"issue":"23","key":"16393_CR12","doi-asserted-by":"publisher","first-page":"8320","DOI":"10.3390\/jcm14238320","volume":"14","author":"N Charbel","year":"2025","unstructured":"Charbel N, Hodroj MH, Skaini MB, Ghais A, Makki M, El Masri A, et al. Acral melanoma in ethnic Lebanese Arab patients: 12-year experience with a rare disease in the MENA region. J Clin Med. 2025;14(23):8320.","journal-title":"J Clin Med"},{"issue":"8","key":"16393_CR13","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.1007\/s00432-022-04430-2","volume":"149","author":"HS Salem","year":"2023","unstructured":"Salem HS. Cancer status in the Occupied Palestinian Territories: types; incidence; mortality; sex, age, and geography distribution; and possible causes. J Cancer Res Clin Oncol. 2023;149(8):5139\u201363.","journal-title":"J Cancer Res Clin Oncol"},{"key":"16393_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12889-016-2715-8","volume":"16","author":"NME Abu-Rmeileh","year":"2016","unstructured":"Abu-Rmeileh NME, Gianicolo EAL, Bruni A, Mitwali S, Portaluri M, Bitar J, et al. Cancer mortality in the West Bank, Occupied Palestinian Territory. BMC Public Health. 2016;16:76.","journal-title":"BMC Public Health"},{"key":"16393_CR15","doi-asserted-by":"publisher","first-page":"100373","DOI":"10.1016\/j.jcpo.2022.100373","volume":"35","author":"S AlWaheidi","year":"2023","unstructured":"AlWaheidi S. Promoting cancer prevention and early diagnosis in the occupied Palestinian territory. J Cancer Policy. 2023;35:100373.","journal-title":"J Cancer Policy"},{"key":"16393_CR16","doi-asserted-by":"publisher","first-page":"997492","DOI":"10.3389\/fonc.2022.997492","volume":"12","author":"R Mansour","year":"2022","unstructured":"Mansour R, Amarin JZ, Al-Ani A, Al-Hussaini M, Mansour A. Palestinian patients with cancer at King Hussein Cancer Center. Front Oncol. 2022;12:997492.","journal-title":"Front Oncol"},{"issue":"4","key":"16393_CR17","first-page":"1137","volume":"20","author":"H Abali","year":"2015","unstructured":"Abali H, Celik I, Karaca B, Turna H, Saglam EK, Akman T, et al. Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study. J BUON. 2015;20(4):1137\u201341.","journal-title":"J BUON"},{"issue":"10","key":"16393_CR18","doi-asserted-by":"publisher","first-page":"994","DOI":"10.15537\/smj.2018.10.22679","volume":"39","author":"AM Albasri","year":"2018","unstructured":"Albasri AM, Borhan WM. Histopathological pattern of skin cancer in Western region of Saudi Arabia: an 11 years experience. Saudi Med J. 2018;39(10):994\u20138.","journal-title":"Saudi Med J"},{"issue":"6","key":"16393_CR19","first-page":"472","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472\u201392.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"16393_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.suc.2019.09.005","volume":"100","author":"S Carr","year":"2020","unstructured":"Carr S, Smith C, Wernberg J. Epidemiology and risk factors of melanoma. Surg Clin North Am. 2020;100(1):1\u201312.","journal-title":"Surg Clin North Am"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16393-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16393-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16393-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:50:18Z","timestamp":1789696218000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16393-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16393"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16393-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"8 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Review Board of Medicare Diagnostic Laboratories, West Bank, Palestine (approval number 2026-HIS-321-7). The study was performed in accordance with the Declaration of Helsinki. As the study was a retrospective analysis of de-identified archival pathology records, the Institutional Review Board waived the requirement for individual informed consent.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. The manuscript contains no individual person\u2019s identifying data, images, or details.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1121"}}